Institut Curie Chooses RayStation for Enhanced Proton Therapy Planning

STOCKHOLM, Nov. 7, 2024 /PRNewswire/ — RaySearch Laboratories AB (publ) has announced that the Institut Curie has ordered the RayStation®* treatment planning system for its three radiotherapy centers in Paris, Orsay, and Saint-Cloud, France. The order was made under the Unicancer 2019 Framework agreement as part of the French hospital network Unicancer.

RayStation will primarily support the Institut Curie Proton Therapy Center in Orsay, one of the three proton centers located in France. All of these centers are now equipped with RayStation technology.

This acquisition allows Institut Curie to access advanced features of RayStation, including LET optimization, adaptive planning, and AI autocontouring for treatment planning with both protons and photons.

Régis Ferrand, Head of Physics at Institut Curie, noted the importance of RayStation’s advanced tools in enhancing the quality of proton treatments.

Johan Löf, founder and CEO of RaySearch, expressed pride in partnering with such a respected institution, highlighting the potential for deepening collaboration in the future.

The total value of this order is approximately 1.7 MEUR, excluding the service agreement, with most of the revenue already recognized in the third quarter of 2024.

For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
johan.lof@raysearchlabs.com

Learn more about us on:

LinkedIn
YouTube
X

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/raysearch-laboratories/r/institut-curie-selects-raystation-for-proton-planning,c4062744

The following files are available for download:

View original content: https://www.prnewswire.com/news-releases/institut-curie-selects-raystation-for-proton-planning-302298575.html

SOURCE RaySearch Laboratories